The marked elevated CCL2 (MCP-1) levels in these people living with HIV despite long-term viral suppression are consistent with others' evidence implicating the CCL2/CCR2 axis as a central component of persistent immune activation, and a mechanistic role in HIV-associated neurologic, cardiovascular, and metabolic disorders [54–57]. This evidence concerns the gene CCR2 and metabolic disease.